Secondary Immune Thrombocytopenia Associated With Asymptomatic COVID-19 Successfully Managed With Intravenous Immunoglobulin and Glucocorticoids.

covid-19 glucocorticoid immune thrombocytopenia intravenous immunoglobulin thrombocytopenia

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
21 May 2021
Historique:
entrez: 28 6 2021
pubmed: 29 6 2021
medline: 29 6 2021
Statut: epublish

Résumé

Immune thrombocytopenia (ITP) is an autoimmune disease characterized by low platelet counts of <100 × 10

Identifiants

pubmed: 34178488
doi: 10.7759/cureus.15153
pmc: PMC8216579
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e15153

Informations de copyright

Copyright © 2021, Ayesh et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Transfusion. 2021 Jul;61(7):2014-2018
pubmed: 33724474
J Thromb Haemost. 2020 Jun;18(6):1469-1472
pubmed: 32302435
Blood. 2009 Mar 12;113(11):2386-93
pubmed: 19005182
Pathobiology. 2021;88(1):15-27
pubmed: 33049751
Br J Haematol. 2020 Jun;189(6):1038-1043
pubmed: 32374026
SN Compr Clin Med. 2020;2(11):2048-2058
pubmed: 32984764
Blood Adv. 2019 Dec 10;3(23):3829-3866
pubmed: 31794604
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013

Auteurs

Hazem Ayesh (H)

Internal Medicine, The University of Toledo, Toledo, USA.

Azizullah Beran (A)

Internal Medicine, The University of Toledo, Toledo, USA.

Mohammed Mhanna (M)

Internal Medicine, The University of Toledo, Toledo, USA.

Srini Hejeebu (S)

Internal Medicine, The University of Toledo, Toledo, USA.

Classifications MeSH